Steven Burke
Chief Tech/Sci/R&D Officer at AKEBIA THERAPEUTICS, INC.
Net worth: 455 977 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Butler | M | 59 | 11 years | |
| Thomas Neenan | M | 66 |
AbFero Pharmaceuticals, Inc.
 AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | - |
| David M. Mosser | M | - |
LeukoSight, Inc.
 LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD. | 18 years |
| Michael Rogers | M | 64 | 6 years | |
| Raymond J. Bergeron | M | - |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | - |
| Myles Wolf | M | 53 | 4 years | |
| Michel Dahan | M | 45 | 11 years | |
| Nicole Hadas | F | 51 | 11 years | |
| Cynthia Smith | F | 55 | 6 years | |
| Ronald Frieson | M | 65 | 3 years | |
| Steven Gilman | M | 71 | 6 years | |
| LeAnne Zumwalt | F | 65 | 3 years | |
| Adrian Adams | M | 73 | 6 years | |
| Gary J. Noel | M | - |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD. | - |
| Mark Grovic | M | - |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology LeukoSight, Inc. develops therapeutics to treat autoimmune and inflammatory diseases. Its categories include apnea, Canadian health and care mall, Canadian pharmacy mall, chronic obstructive airway disease and erectile dysfunction. The company was founded by David M. Mosser in 2007 and is headquartered in College Park, MD. | - |
| Michael Rabinowitz | M | - | - | |
| Nicholas Grund | M | 54 | - | |
| Tracey Vetterick | F | - | 2 years | |
| Michael Penington | M | 66 |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | - |
| Christian Barnes | M | - | - | |
| Meredith Bowman | F | - | 2 years | |
| Carolyn Rucci | F | - | 3 years | |
| Mercedes Carrasco | F | - | - | |
| Richard Malabre | M | 63 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Eldridge | M | 61 | 7 years | |
| Timothy Noyes | M | 62 |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 21 years |
| Gregory D. Phelps | M | 75 | 8 years | |
| David Spellman | M | 48 | 3 years | |
| F. Nicholas Franano | M | 57 | 13 years | |
| Jason Amello | M | 55 | 7 years | |
| Garen Bohlin | M | 76 | - | |
| Maxine Gowen | M | 66 | 7 years | |
| Hubert Birner | M | 57 | - | |
| Ellen Snow | F | - | 1 years | |
| Mark Enyedy | M | 60 | 3 years | |
| William P. Whitaker | M | - | 8 years | |
| Jodie Morrison | F | 48 | 2 years | |
| E. Scott Toner | M | - | - | |
| Dmitry Kobyzev | M | 38 | 2 years | |
| Matthew P. Kowalsky | M | 52 | 3 years | |
| Violetta Cotreau | F | 51 | 2 years | |
| Muffy Carter | F | 71 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 10 years |
| Michael Heffernan | M | 59 | 4 years | |
| Timothy Haines | M | 67 | 5 years | |
| Robert Carpenter | M | 79 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 9 years |
| Scott Canute | M | 63 | 4 years | |
| Daniel Gottlieb | M | 53 | - | |
| Brendan M. O'Leary | M | 52 | - | |
| John Freund | M | 70 | - | |
| Paul Mellett | M | 68 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 3 years |
| Tony Kingsley | M | 60 | 4 years | |
| Jonathan Leff | M | 55 | 2 years | |
| John Najim | M | 48 | 10 years | |
| Dell Faulkingham | M | 51 | - | |
| Bradley Hartman | M | - | - | |
| Rita Jain | M | 61 | 2 years | |
| Pamela Gustafson | F | - | - | |
| David M. Davidson | M | 60 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 5 years |
| Jennifer Panagoulias | F | - | - | |
| David Rosenbaum | M | 63 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 5 years |
| Marco D. Wong | M | - | - | |
| Mark B. Skaletsky | M | 75 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 7 years |
| Douglas Reed | M | 70 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 1 years |
| Joseph E. Tyler | M | 74 | - | |
| Todd Foley | M | 52 | 2 years | |
| Paul Hastings | M | 64 | - | |
| Mark J. Fitzpatrick | M | 61 | 4 years | |
| Kristie Wagner | F | 57 | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 68 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steven Burke
- Personal Network
